Comparative Study
doi: 10.1128/AAC.40.3.822.
In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs
Affiliations
- PMID: 8851624
- PMCID: PMC163211
- DOI: 10.1128/AAC.40.3.822
Item in Clipboard
Comparative Study
In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs
Antimicrob Agents Chemother.
1996 Mar.
Abstract
A total of 53 Cryptococcus neoformans strains, including clinical and environmental Brazilian isolates, were tested for their susceptibilities to amphotericin B, 5-flucytosine, ketoconazole, fluconazole, and itraconazole. The tests were performed according to the National Committee of Clinical Laboratory Standards recommendations (document M27-P). In general, there was a remarkable homogeneity of results for all strains, and comparable MICs were found for environmental and clinical isolates. This paper represents the first contribution in which susceptibility data for Brazilian C. neoformans isolates are provided.
Similar articles
-
Antifungal susceptibilities of Cryptococcus species complex isolates from AIDS and non-AIDS patients in Southeast China.Braz J Infect Dis. 2012 Mar-Apr;16(2):175-9. doi: 10.1016/s1413-8670(12)70301-x. Braz J Infect Dis. 2012. PMID: 22552461
-
In vitro susceptibility to antifungal agents of clinical and environmental Cryptococcus neoformans isolated in Southern of Brazil.Rev Inst Med Trop Sao Paulo. 2001 Sep-Oct;43(5):267-70. doi: 10.1590/s0036-46652001000500006. Rev Inst Med Trop Sao Paulo. 2001. PMID: 11696849
-
Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.Diagn Microbiol Infect Dis. 1995 Nov;23(3):99-103. doi: 10.1016/0732-8893(95)00169-7. Diagn Microbiol Infect Dis. 1995. PMID: 8849653
-
Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.Rev Inst Med Trop Sao Paulo. 2005 Sep-Oct;47(5):253-6. doi: 10.1590/s0036-46652005000500003. Epub 2005 Nov 16. Rev Inst Med Trop Sao Paulo. 2005. PMID: 16302107
-
The Environmental Effects on Virulence Factors and the Antifungal Susceptibility of Cryptococcus neoformans.Int J Mol Sci. 2021 Jun 11;22(12):6302. doi: 10.3390/ijms22126302. Int J Mol Sci. 2021. PMID: 34208294 Free PMC article. Review.
Cited by
-
Antifungal susceptibilities of Cryptococcus neoformans.Emerg Infect Dis. 2004 Jan;10(1):143-5. doi: 10.3201/eid1001.020779. Emerg Infect Dis. 2004. PMID: 15078612 Free PMC article.
-
Advanced approach for antifungal susceptibility and characterization of resistance properties in clinical and environmental isolates of Cryptococcus species complex.Infect Med (Beijing). 2022 Aug 29;1(3):147-153. doi: 10.1016/j.imj.2022.08.006. eCollection 2022 Sep. Infect Med (Beijing). 2022. PMID: 38077629 Free PMC article.
-
In vitro antifungal susceptibility of Cryptococcus gattii.J Clin Microbiol. 2004 Oct;42(10):4815-7. doi: 10.1128/JCM.42.10.4815-4817.2004. J Clin Microbiol. 2004. PMID: 15472349 Free PMC article.
-
Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans.Mycopathologia. 2012 Jun;173(5-6):427-33. doi: 10.1007/s11046-012-9528-9. Epub 2012 Feb 22. Mycopathologia. 2012. PMID: 22354778
-
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.Mycopathologia. 2005 Aug;160(1):9-14. doi: 10.1007/s11046-005-6332-9. Mycopathologia. 2005. PMID: 16160762
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
